Z22.350
Carrier of carbapenem-resistant Enterobacterales
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code Z22.350 pertains to individuals who are carriers of carbapenem-resistant Enterobacterales (CRE). Being a carrier means that a person harbors these bacteria in their body, particularly in the intestines or other parts, without necessarily showing symptoms of illness. While carriers are typically asymptomatic, they pose a risk of spreading the resistant bacteria to others and may develop infections themselves if the bacteria invade other parts of the body. Recognizing and understanding carrier status is important for infection control and preventing transmission within communities and healthcare settings.
Causes & Symptoms
Clinical Causes: Contact with other carriers or infected individuals Hospitalization or residing in healthcare facilities involved in infection control lapses Use of antibiotics that selective pressure towards resistant bacteria Travel to regions with high prevalence of CRE Compromised immune system leading to colonization Underlying chronic health conditions or recent surgeries
Key Symptoms: Typically asymptomatic, showing no signs of infection In some cases, it may lead to urinary tract infections, bloodstream infections, or other severe infections if bacteria invade sterile sites No specific symptoms indicate carrier status; testing is required to confirm presence
Diagnostic & Treatment
Diagnosis Path: Identification of CRE carriage is primarily through laboratory testing, such as rectal swabs or stool samples, which detect the presence of resistant bacteria. These tests are often arranged for individuals at high risk or during screening in healthcare environments. Molecular methods and culture techniques are employed to determine resistance patterns and confirm CRE colonization.
Treatment Protocols: Generally, carriage of CRE does not require treatment unless it progresses to infection. If infection develops, treatment options are limited and tailored according to antimicrobial susceptibility testing. Since carriers are typically asymptomatic, the focus is on infection control measures, including contact precautions and hygiene practices, to prevent spread. Long-term carriage may sometimes be managed through decolonization strategies; however, these are not universally effective and are subject to clinical judgment.
Clinical Advice & FAQs
Billing Guidance
Is Z22.350 a billable ICD-10 code?
Yes, Z22.350 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z22.350?
Clinical documentation must specify the nature of Carrier of carbapenem-resistant Enterobacterales and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
